These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 13621643)
1. Dangers of uric-acid excretion during treatment of leukaemia and lymphosarcoma. GREENBAUM D; STONE HF Lancet; 1959 Jan; 1(7063):73-5. PubMed ID: 13621643 [No Abstract] [Full Text] [Related]
2. Uric acid and phosphorus excretion in dogs with lymphosarcoma. Page RL; Leifer CE; Matus RE Am J Vet Res; 1986 Apr; 47(4):910-2. PubMed ID: 3754406 [TBL] [Abstract][Full Text] [Related]
3. Studies on leukemia. I. Uric acid excretion. SANDBERG AA; CARTWRIGHT GE; WINTROBE MM Blood; 1956 Feb; 11(2):154-66. PubMed ID: 13284066 [No Abstract] [Full Text] [Related]
4. Pattern of uric-acid excretion during a leukaemic remission. DICKINSON CJ Br Med J; 1960 Apr; 1(5178):1027-9. PubMed ID: 13816601 [No Abstract] [Full Text] [Related]
5. Urate excretion in patients with acute leukemia. HOLLAND JF; SHARPE W; MAMROD LM; DOWD E; HARTSOCK M J Natl Cancer Inst; 1959 Nov; 23():1097-105. PubMed ID: 14402606 [No Abstract] [Full Text] [Related]
6. Hyperuricemia in leukemia and lymphoma. II. Treatment. Pochedly C N Y State J Med; 1973 May; 73(10):1194-200. PubMed ID: 4572538 [No Abstract] [Full Text] [Related]
7. [Urinary purines and uric acid excretion in patients with various blood contents of cobalamin compounds]. Miasishcheva NV; Sheremet ZI; Levina GD; Lorie IuI; Raushenbakh MO Probl Gematol Pereliv Krovi; 1970 Jan; 15(1):36-43. PubMed ID: 5420382 [No Abstract] [Full Text] [Related]
11. [Usefulness of uric acid clearance determination in the evaluation of treatment of acute leukemia]. Kordecki H; Urasiński I; Wojdyła M Pol Tyg Lek; 1978 Jan; 33(1):17-9. PubMed ID: 643697 [No Abstract] [Full Text] [Related]
13. [Danger of hyperuricemia in the treatment of acute leukemia, lymphosarcoma and reticulosarcoma]. Armata J Pol Tyg Lek; 1974 Jun; 29(23):1005-6. PubMed ID: 4601064 [No Abstract] [Full Text] [Related]
14. Urinary excretion of N-acetyl-beta-D-glucosaminidase and alpha1-microglobulin in children with proliferative blood diseases. Zajaczkowska M; Stefaniak J; Sikora P; Choma-Smaga M; Filiks-Litwin B; Szajner-Milart I; Borzecka H Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):348-53. PubMed ID: 15315013 [TBL] [Abstract][Full Text] [Related]
16. Recombinant urate oxidase for the prophylaxis or treatment of hyperuricemia in patients With leukemia or lymphoma. Pui CH; Mahmoud HH; Wiley JM; Woods GM; Leverger G; Camitta B; Hastings C; Blaney SM; Relling MV; Reaman GH J Clin Oncol; 2001 Feb; 19(3):697-704. PubMed ID: 11157020 [TBL] [Abstract][Full Text] [Related]
17. Hyperuricemia with uric acid nephropathy following nitrogen mustard therapy of lymphosarcoma; report of a case. WINKLER JW Med Ann Dist Columbia; 1959 Feb; 28(2):77-8 passim. PubMed ID: 13643089 [No Abstract] [Full Text] [Related]
18. [Formation of urinary calculi and uric acid findings in children with leukemia]. Moe PJ Tidsskr Nor Laegeforen; 1970 Jun; 90(11):1201-5. PubMed ID: 5450743 [No Abstract] [Full Text] [Related]
19. Prognostic value of uric acid excretion in steroid therapy of acute leukemia. SHANBROM E Am J Med Sci; 1962 Jan; 243():13-9. PubMed ID: 13911205 [No Abstract] [Full Text] [Related]
20. Folic acid and other absorption tests in lymphosarcoma, chronic lymphocytic leukaemia, and some related conditions. PITNEY WR; JOSKE RA; MACKINNON NL J Clin Pathol; 1960 Sep; 13(5):440-7. PubMed ID: 13736101 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]